Header image
Václavková Jana Ph.D.
Error message
User warning: Trying to overwrite a cache redirect for "entity_view:node:525:template_managed:[languages:language_interface]=en:[theme]=imtm:[timezone]=Europe/Prague:[user.permissions]=47340370dca61f273f6f310ffd4df7ab1bfdd3675a7f1c0dc2c39c3e3b4922bf" with one that has nothing in common, old one at address "languages:language_interface, theme, user.permissions, timezone" was pointing to "url.query_args:language", new one points to "url.query_args:language_content_entity". in Drupal\Core\Cache\VariationCache->set() (line 138 of core/lib/Drupal/Core/Cache/VariationCache.php).Journals
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4.
Nature.
2017,
552(7684),
194-199,
ISSN: 0028-0836,
PMID: 29211715,
Proteomic profiling reveals DNA damage, nucleolar and ribosomal stress are the main responses to oxaliplatin treatment in cancer cells.
Journal of Proteomics.
2017,
162,
73-85,
ISSN: 1874-3919,
PMID: 28478306,
Books & book chapters
Western blot analysis,
1.vyd.,
Olomouc,
Palacky University,
2021,
33,
253-264,
Dedication: LO1304,
ISBN: 978-80-244-6049-9,
Intellectual property
METHOD FOR NON-INVASIVE ASTHMA TREATMENT STRATIFICATION - EP 25223197.2 (Džubák)
Filed Application EP 25223197.2
Ownership: Palacký University Olomouc. Inventors: DŽUBÁK Petr, HAJDÚCH Marián, VÁCLAVKOVÁ Jana, KOUŘILOVÁ Pavla, KOPŘIVA František.
Status: Patent pending
Master mentorship
Korbelová Mária
Identification of molecular targets of biologically active molecules
Status:
Graduated from 2023 to 2024.
Neubauerová Eva
Identification of molecular targets by proteomic methods
Status:
Graduated from 2014 to 2016.
Králiková Kateřina
Evaluation of the cellular response to biologically active molecule treatment using proteomic methods
Status:
Graduated from 2020 to 2022.
Bachelor mentorship
Machačová Zuzana M.Sc.
Identification of Proteomic Molecular Targets of Biologically Active Molecules
Status:
Graduated from 2017 to 2019.
Zbořilová Pavlína
Single-cell proteomics: optimization of sample preparation for LC-MS/MS analysis
Status:
Ongoing from 2026.